MedCity News December 26, 2025
The technology already exists that would allow us to close the loop between physiological dysfunction and neural adaptation in real time. The question is not if, but how, rapidly this capability will reshape therapeutic paradigms and the economics that sustain them.
Globally, the pharma industry invests over $200 billion annually in developing molecules that act on the body. Meanwhile, a very sophisticated and much less expensive drug delivery system remains largely untapped as a therapeutic mechanism itself: the human nervous system.
What if we could unlock this delivery system to replace or enhance drug-based interventions?
The technology already exists that would allow us to close the loop between physiological dysfunction and neural adaptation in real time. The question is...
Today's Sponsors
Today's Sponsor